Cambodia vs Syrian Arab Republic: Deaths from Parkinson's disease
Cambodia
419.96 deaths
in 2021
Syrian Arab Republic
426.41 deaths
in 2021
Cambodia rank
71st
Syrian Arab Republic rank
70th
Deaths from Parkinson's disease over time
- Cambodia
- Syrian Arab Republic
How they compare
Syrian Arab Republic currently reports 426.41 deaths against 419.96 deaths in Cambodia, a difference of 6.45 deaths.
Across all 22 years both countries report, Syrian Arab Republic has been ahead every year.
Cambodia ranks 71st and Syrian Arab Republic ranks 70th of 194 countries.
Syrian Arab Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cambodia | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 190.04 deaths | 286.65 deaths | 96.61 deaths | Syrian Arab Republic |
| 2010s | 320.03 deaths | 388.91 deaths | 68.88 deaths | Syrian Arab Republic |
| 2020s | 419.97 deaths | 428.74 deaths | 8.77 deaths | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher deaths from parkinson's disease, Cambodia or Syrian Arab Republic?
- Syrian Arab Republic, at 426.41 deaths against 419.96 deaths in Cambodia as of 2021.
- What is the difference in deaths from parkinson's disease between Cambodia and Syrian Arab Republic?
- 6.45 deaths, with Syrian Arab Republic ahead.
- How many years of comparable data are there for Cambodia and Syrian Arab Republic?
- 22 years are reported by both, from 2000 to 2021.
- How do Cambodia and Syrian Arab Republic rank globally for deaths from parkinson's disease?
- Cambodia ranks 71st and Syrian Arab Republic ranks 70th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Deaths from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes.